1-chloro-2,4-dinitrobenzene affects binding ISO VSNL1 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to VSNL1 protein CTD PMID:32991956 17beta-estradiol decreases expression ISO VSNL1 (Homo sapiens) 6480464 Estradiol results in decreased expression of VSNL1 mRNA CTD PMID:20106945 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VSNL1 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of VSNL1 mRNA CTD PMID:30165855 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VSNL1 mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO VSNL1 (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VSNL1 mRNA] CTD PMID:11007951 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of VSNL1 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Vsnl1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of VSNL1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO VSNL1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of VSNL1 mRNA CTD PMID:11007951 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-methylcholine affects expression ISO VSNL1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of VSNL1 mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol increases expression ISO Vsnl1 (Mus musculus) 6480464 bisphenol S results in increased expression of VSNL1 mRNA CTD PMID:30951980 5-bromo-2'-deoxyuridine decreases response to substance ISO Vsnl1 (Mus musculus) 6480464 VSNL1 protein results in decreased susceptibility to Bromodeoxyuridine CTD PMID:20419170 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of VSNL1 mRNA CTD PMID:24780913 7,12-dimethyltetraphene multiple interactions ISO Vsnl1 (Mus musculus) 6480464 VSNL1 protein results in decreased susceptibility to [9 more ... CTD PMID:20419170 aflatoxin B1 affects expression ISO VSNL1 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of VSNL1 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO VSNL1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of VSNL1 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO VSNL1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of VSNL1 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO VSNL1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of VSNL1 mRNA CTD PMID:21934132 and PMID:23724009 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of VSNL1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO VSNL1 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of VSNL1 mRNA CTD PMID:33212167 arsane multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VSNL1 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VSNL1 mRNA CTD PMID:32525701 arsenite(3-) increases methylation ISO VSNL1 (Homo sapiens) 6480464 arsenite results in increased methylation of VSNL1 promoter CTD PMID:23974009 arsenous acid decreases expression ISO VSNL1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of VSNL1 mRNA CTD PMID:26705709 azathioprine decreases expression ISO VSNL1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of VSNL1 mRNA CTD PMID:22623647 benzo[a]pyrene decreases response to substance ISO Vsnl1 (Mus musculus) 6480464 VSNL1 protein results in decreased susceptibility to Benzo(a)pyrene CTD PMID:20419170 benzo[a]pyrene decreases methylation ISO VSNL1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of VSNL1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO VSNL1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of VSNL1 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO VSNL1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of VSNL1 mRNA CTD PMID:20106945 more ... benzo[e]pyrene increases methylation ISO VSNL1 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of VSNL1 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO VSNL1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of VSNL1 mRNA CTD PMID:31163220 bisphenol A decreases expression ISO VSNL1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of VSNL1 mRNA CTD PMID:31715268 bisphenol A decreases expression ISO Vsnl1 (Mus musculus) 6480464 bisphenol A results in decreased expression of VSNL1 mRNA CTD PMID:32156529 bisphenol A multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of VSNL1 gene CTD PMID:31601247 bisphenol A affects expression ISO VSNL1 (Homo sapiens) 6480464 bisphenol A affects the expression of VSNL1 mRNA CTD PMID:30903817 bisphenol A increases expression ISO Vsnl1 (Mus musculus) 6480464 bisphenol A results in increased expression of VSNL1 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of VSNL1 gene CTD PMID:28505145 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of VSNL1 mRNA CTD PMID:25181051 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of VSNL1 protein CTD PMID:28903499 cadmium atom decreases expression ISO VSNL1 (Homo sapiens) 6480464 Cadmium results in decreased expression of VSNL1 mRNA CTD PMID:24376830 cadmium atom multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VSNL1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of VSNL1 mRNA CTD PMID:35301059 calcitriol decreases expression ISO VSNL1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of VSNL1 mRNA CTD PMID:16002434 cannabidiol decreases expression ISO VSNL1 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of VSNL1 mRNA CTD PMID:33244087 carbon nanotube decreases expression ISO Vsnl1 (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of VSNL1 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO VSNL1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to VSNL1 gene] CTD PMID:28238834 chloroquine decreases expression EXP 6480464 Chloroquine results in decreased expression of VSNL1 mRNA CTD PMID:19393257 clozapine decreases expression EXP 6480464 Clozapine results in decreased expression of VSNL1 mRNA CTD PMID:12437575 copper atom increases expression EXP 6480464 Copper results in increased expression of VSNL1 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of VSNL1 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO VSNL1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of VSNL1 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO Vsnl1 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of VSNL1 mRNA CTD PMID:29279043 cycloheximide multiple interactions ISO VSNL1 (Homo sapiens) 6480464 Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of VSNL1 mRNA] CTD PMID:11007951 cyclosporin A decreases expression ISO VSNL1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of VSNL1 mRNA CTD PMID:20106945 more ... diarsenic trioxide decreases expression ISO VSNL1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of VSNL1 mRNA CTD PMID:26705709 dibutyl phthalate increases expression ISO Vsnl1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of VSNL1 mRNA CTD PMID:21266533 dicrotophos decreases expression ISO VSNL1 (Homo sapiens) 6480464 dicrotophos results in decreased expression of VSNL1 mRNA CTD PMID:28302478 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of VSNL1 mRNA CTD PMID:21658437 dioxygen multiple interactions ISO Vsnl1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of VSNL1 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO VSNL1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of VSNL1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of VSNL1 mRNA CTD PMID:29391264 ethanol increases expression ISO Vsnl1 (Mus musculus) 6480464 Ethanol results in increased expression of VSNL1 mRNA CTD PMID:30319688 ethanol multiple interactions ISO Vsnl1 (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of VSNL1 mRNA CTD PMID:30319688 fenamidone decreases expression ISO Vsnl1 (Mus musculus) 6480464 fenamidone results in decreased expression of VSNL1 mRNA CTD PMID:27029645 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of VSNL1 mRNA CTD PMID:30307764 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of VSNL1 mRNA CTD PMID:18035473 fulvestrant multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of VSNL1 gene CTD PMID:31601247 genistein increases expression ISO Vsnl1 (Mus musculus) 6480464 Genistein results in increased expression of VSNL1 mRNA CTD PMID:32186404 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of VSNL1 mRNA CTD PMID:12437575 hydrogen peroxide affects expression ISO VSNL1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of VSNL1 mRNA CTD PMID:20044591 and PMID:23410634 hydroquinone decreases expression ISO VSNL1 (Homo sapiens) 6480464 hydroquinone results in decreased expression of VSNL1 mRNA CTD PMID:31256213 ivermectin decreases expression ISO VSNL1 (Homo sapiens) 6480464 Ivermectin results in decreased expression of VSNL1 protein CTD PMID:32959892 lead(0) affects expression ISO VSNL1 (Homo sapiens) 6480464 Lead affects the expression of VSNL1 mRNA CTD PMID:28903495 leflunomide decreases expression ISO VSNL1 (Homo sapiens) 6480464 leflunomide results in decreased expression of VSNL1 mRNA CTD PMID:28988120 lipopolysaccharide multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide increases expression ISO VSNL1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of VSNL1 mRNA CTD PMID:35811015 menadione affects expression ISO VSNL1 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of VSNL1 mRNA CTD PMID:23410634 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of VSNL1 mRNA CTD PMID:16507785 metformin decreases expression EXP 6480464 Metformin results in decreased expression of VSNL1 mRNA CTD PMID:31324951 methapyrilene increases methylation ISO VSNL1 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of VSNL1 intron CTD PMID:30157460 methylmercury chloride decreases expression ISO VSNL1 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of VSNL1 mRNA CTD PMID:28001369 nevirapine decreases expression EXP 6480464 Nevirapine metabolite results in decreased expression of VSNL1 mRNA and Nevirapine results in decreased expression of VSNL1 mRNA CTD PMID:23947594 nickel atom increases expression ISO VSNL1 (Homo sapiens) 6480464 Nickel results in increased expression of VSNL1 mRNA CTD PMID:24768652 and PMID:25583101 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of VSNL1 mRNA CTD PMID:33484710 O-methyleugenol decreases expression ISO VSNL1 (Homo sapiens) 6480464 methyleugenol results in decreased expression of VSNL1 mRNA CTD PMID:32234424 ozone multiple interactions ISO Vsnl1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of VSNL1 mRNA CTD PMID:34911549 paracetamol decreases expression ISO VSNL1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of VSNL1 mRNA and Acetaminophen results in decreased expression of VSNL1 protein CTD PMID:22230336 and PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of VSNL1 mRNA CTD PMID:33387578 paracetamol increases expression ISO VSNL1 (Homo sapiens) 6480464 Acetaminophen results in increased expression of VSNL1 mRNA CTD PMID:26690555 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of VSNL1 mRNA CTD PMID:32680482 perfluorononanoic acid decreases expression ISO VSNL1 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of VSNL1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid affects expression ISO Vsnl1 (Mus musculus) 6480464 perfluorooctane sulfonic acid affects the expression of VSNL1 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO Vsnl1 (Mus musculus) 6480464 perfluorooctanoic acid affects the expression of VSNL1 mRNA CTD PMID:19429403 perfluorooctanoic acid decreases expression ISO VSNL1 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of VSNL1 protein CTD PMID:26879310 phenylmercury acetate decreases expression ISO VSNL1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of VSNL1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSNL1 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate decreases response to substance ISO Vsnl1 (Mus musculus) 6480464 VSNL1 protein results in decreased susceptibility to Tetradecanoylphorbol Acetate CTD PMID:20419170 phorbol 13-acetate 12-myristate multiple interactions ISO Vsnl1 (Mus musculus) 6480464 VSNL1 protein results in decreased susceptibility to [9 more ... CTD PMID:20419170 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of VSNL1 mRNA CTD PMID:26923065 quercetin decreases expression ISO VSNL1 (Homo sapiens) 6480464 Quercetin results in decreased expression of VSNL1 mRNA CTD PMID:21632981 rotenone decreases expression ISO VSNL1 (Homo sapiens) 6480464 Rotenone results in decreased expression of VSNL1 mRNA CTD PMID:29955902 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO VSNL1 (Homo sapiens) 6480464 Silicon Dioxide results in decreased expression of VSNL1 mRNA CTD PMID:25351596 sodium arsenate multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of VSNL1 mRNA CTD PMID:32525701 sodium arsenite affects methylation ISO VSNL1 (Homo sapiens) 6480464 sodium arsenite affects the methylation of VSNL1 gene CTD PMID:28589171 sodium arsenite decreases expression ISO Vsnl1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of VSNL1 mRNA CTD PMID:37682722 sodium arsenite increases expression ISO VSNL1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of VSNL1 mRNA CTD PMID:34032870 sodium arsenite decreases expression ISO VSNL1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of VSNL1 mRNA CTD PMID:29301061 sunitinib decreases expression ISO VSNL1 (Homo sapiens) 6480464 Sunitinib results in decreased expression of VSNL1 mRNA CTD PMID:31533062 temozolomide increases expression ISO VSNL1 (Homo sapiens) 6480464 Temozolomide results in increased expression of VSNL1 mRNA CTD PMID:31758290 tert-butyl hydroperoxide affects expression ISO VSNL1 (Homo sapiens) 6480464 tert-Butylhydroperoxide affects the expression of VSNL1 mRNA CTD PMID:23410634 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of VSNL1 mRNA CTD PMID:32741896 Theaflavin 3,3'-digallate affects expression ISO VSNL1 (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate affects the expression of VSNL1 mRNA CTD PMID:34925699 titanium dioxide decreases expression ISO Vsnl1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of VSNL1 mRNA CTD PMID:23409001 tolcapone affects binding EXP 6480464 tolcapone binds to VSNL1 protein CTD PMID:19783845 trichostatin A decreases expression ISO VSNL1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of VSNL1 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSNL1 mRNA CTD PMID:27188386 triclosan decreases expression ISO VSNL1 (Homo sapiens) 6480464 Triclosan results in decreased expression of VSNL1 mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO Vsnl1 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of VSNL1 mRNA CTD PMID:19042947 uranium atom affects expression ISO VSNL1 (Homo sapiens) 6480464 Uranium affects the expression of VSNL1 mRNA CTD PMID:15672453 urethane decreases expression ISO VSNL1 (Homo sapiens) 6480464 Urethane results in decreased expression of VSNL1 mRNA CTD PMID:28818685 valproic acid decreases expression ISO Vsnl1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of VSNL1 mRNA CTD PMID:24896083 valproic acid decreases expression ISO VSNL1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of VSNL1 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO VSNL1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of VSNL1 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO VSNL1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VSNL1 mRNA CTD PMID:27188386